PhoenixBio Group would like to express its gratitude to the valued clients and collaborators! Our success is the result of your continuous trust and support! Your front-edge research resulted…
Inaugural Asian Drug-Drug Interactions (DDI) conference ADDI 2018 was held on December 3-6 in the Chinese University of Hong Kong. The event was especially interesting, as PXB-Mouse® and PXB-cells®…
If you did not attend this year’s annual AASLD’s Liver Meeting® in San Francisco (CA), you may be interested in the most recent presentations relevant to chimeric mice with…
As our facility expansion is progressing, KMT Hepatech is currently seeking additional staff member for the PXB-Cells® Production and Transplantation Unit. The PXB-Cells® Production and Transplantation Unit produces cultured PXB-Cells® (freshly isolated human hepatocytes) for distribution upon clients’ request. In addition, this unit performs and oversees the transplantations of human hepatocytes to generate PXB mice – cDNA-uPA/scid chimeric mice with highly humanized liver.
Full job posting is provided below: (more…)
PhoenixBio Group would be pleased to welcome you at the Booth #20 at 54th Congress of the European Societies of Toxicology 2018. The Meeting is hosting plenary sessions, features…
As a part of PhoenixBio Group, we would be pleased to see you at the exhibition booth #300 at 22nd North American ISSX Meeting. The Meeting is hosting plenary…
The International NASH Day is the 1st edition of a worldwide movement initiated by the endowment fund The NASH Education ProgramTM aimed at raising awareness about NonAlcoholic SteatoHepatitis (better…
KMT Hepatech, Inc. - PhoenixBio Group will participate in the Business Forum at BIO International Convention in Boston. Companies or individuals attending BIO One-on-One Partnering can schedule meeting with…
KMT Hepatech, Inc. (“KMT”), a part of PhoenixBio group, announced plans to expand staff and operations by providing services with PXB-Mouse® and starting the production of the PXB-Cells® – hepatocytes isolated from cDNA-uPA/SCID mice…
KMT Hepatech, Inc. (“KMT”) announced today that it has reached an agreement to join efforts with PhoenixBio Co., Ltd. (PhoenixBio). Together they will advance the use of the cDNA-uPA/SCID mouse model with…
